Celldex Therapeutics, Inc (NASDAQ:CLDX)
|
5.10 -0.05 (-0.97%) Mar 16 - Close |
|
|
|
- Compare CLDX with:
- View: Line | Candlestick
Company Profile
Celldex Therapeutics, Inc
119 Fourth Avenue
Needham, MA 02494-2725
United States - Map
Phone: (781) 433-0771
Fax: (781) 433-0262
Website: www.celldextherapeutics.com
CEO: Anthony S. Marucci
Employees: 78
Sector: Healthcare
Industry Group: Drugs
Industry: Diagnostic Substances
Engd in dev of diagnostic prods;immune disorders
The company is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease.
Recent news for CLDX
-
CELLDEX THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
EDGAR Online - Mar 12 at 4:20PM (EST)
-
Celldex Therapeutics to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference
Business Wire - Mar 11 at 2:56PM (EST)
-
Celldex Therapeutics to Present at the Cowen & Company 30th Annual Health Care Conference
Business Wire - Mar 08 at 9:58AM (EST)
-
Celldex takes larger 4Q loss on acquisition costs
AP - Mar 04 at 10:57AM (EST)
-
DivX, Coldwater Creek: Early Volume Plays
TheStreet.com - Mar 04 at 9:59AM (EST)
-
2010 Corporate Update Conference Call and Webcast scheduled for 9:00 am ET today
CCBN - Mar 04 at 9:00AM (EST)
-
EDGAR Online - Mar 04 at 8:00AM (EST)
-
Q4 2009 Celldex Therapeutics, Inc. Earnings Release - Before Market Open
CCBN - Mar 04 at 7:07AM (EST)
-
Celldex Reports Fourth Quarter and Fiscal 2009 Financial Results
Business Wire - Mar 04 at 7:00AM (EST)
-
2010 Corporate Update Conference Call and Webcast scheduled for Thu, Mar 4
CCBN - Mar 03 at 10:42PM (EST)